BASF and Avantium to Start JV New Polymers-Player: BASF and Avantium Plan to Cooperate on Bio-Based Chemicals
Technical know-ho from the Netherlands backed up by the ressources of a global chemical giant shall help to give bio-based polymers a distinctive boost: BASF and Avantium plan to establish a joint venture company for the production and marketing of furandicarboxylic acid (FDCA) based on renewable resources, the main new building block for polyethylenefuranoate (PEF)
Ludwigshafen; Amsterdam/Netherlands – The new JV shall further develop and license Avantium’s production process at and industrial scale. For this purpose, a new industrial scale demonstration plant with an annual capacity of up to 50,000 tons at BASF’s Verbund site in Antwerp, Belgium. FDCA, an important PEF precursor, is produced from renewable resources.
“With the planned joint venture, we want to combine Avantium’s specific production technology and application know-how for FDCA and PEF with the strengths of BASF,” said Dr. Stefan Blank, President of BASF’s Intermediates division. “Of particular importance is our expertise in market development and large-scale production as an established and reliable chemical company in the business of intermediates and polymers,” Blank added.
Future production plants shall use the YXY process developed by Avantium in Amsterdam and Geleen, Netherlands, for the production of FDCA. It is intended to further develop this process as well as to construct a reference plant for the production of FDCA with an annual capacity of up to 50,000 metric tons per year at BASF’s Verbund site in Antwerp, Belgium. The aim is to build up world-leading positions in FDCA and PEF, and subsequently license the technology for industrial scale application.
„Partnering with the number one chemical company in the world, provides us with access to the capabilities that are required to bring this technology to industrialization,” explained Tom van Aken, Chief Executive Officer of Avantium. “Together with BASF, we plan to start production of FDCA to enable the first commercial launch of this exciting bio-based material and to further develop and grow the market to its full potential,” van Aken continued.